4 of the Top 20 Pharma Companies Adopt Veeva Align
Today at Veeva European Commercial & Medical Summit , one of the largest life sciences events for commercial and medical affairs professionals in Europe, Veeva Systems (NYSE:VEEV) announced that four of the top 20 pharmaceutical companies have adopted Veeva Align across various regions to perform fast, accurate territory alignments. Veeva also launched new target planning capabilities in Veeva Align to simplify the creation of multichannel cycle plans and deliver them in Veeva CRM , helping sales operations more efficiently drive execution across the right mix of channels.
Companies such as Astellas use Veeva Align to significantly reduce time to create alignments. “Operating with greater agility is a key principle for Astellas,” said Ian Knowlton, senior director, head of CRM, Astellas, a leading global pharmaceutical company. “Veeva Align allows us to make major changes to sales force territories faster and more precisely. Alignments that used to take five days now take as little as a few minutes.”
Organizations typically rely on spreadsheets, multiple systems, or third-party vendors to support territory alignments, which are often a time-consuming, costly administrative burden. As a result, sales operations struggles to keep pace with customer changes and assign the right field resources to the right physicians.
Veeva Align helps companies deliver the right alignments faster. On average, Veeva Align customers decreased time to create territory alignments by 75% and saw a tenfold reduction in process steps. Integration with Veeva CRM eliminates handoffs and enables seamless field collaboration. Field reps can provide feedback right in Veeva CRM, allowing sales operations to improve accuracy and more quickly optimize territory alignments.
To help life sciences companies transform their customer engagement across multiple channels, Veeva announced new target planning capabilities in Veeva Align to simplify multichannel cycle planning. Sales operations can set activity goals using criteria such as customer segmentation and sales history, prioritize customer targets, generate multichannel cycle plans, and deliver them directly into Veeva CRM for the field to execute. This makes planning easier and more efficient as companies expand their customer engagement across various channels.
“Veeva Align gives sales operations full control of their multichannel activity planning,” said Jan van den Burg, Veeva vice president of commercial strategy in Europe. “For the first time, companies can align and target their customers in a single application to close the gap between their sales strategy and execution and more quickly respond to the needs of the business.”
To learn more about how customers are performing faster, more accurate territory alignments with Veeva Align, join Astellas for their session today at Veeva European Commercial & Medical Summit at 2:30 p.m. and AbbVie at 4:20 p.m.
In other news today, Veeva also announced Veeva CRM Engage Webinar , the first purpose-built application to manage compliant virtual events in the life sciences industry, and Veeva Vault PromoMats Brand Portal , a new digital asset management capability that makes it simple for brand managers to create portals and organize and showcase content within Veeva Vault PromoMats . Read the Veeva CRM Engage Webinar news and the Vault PromoMats Brand Portal news to learn more.
Veeva European Commercial & Medical Summit is one of the industry’s largest European events dedicated to commercial and medical solutions for life sciences. This year more than 800 life sciences professionals and industry experts will participate in the two-day conference to learn, connect, and share valuable insight on industry trends and best practices.
For more on Veeva Align, visit: veeva.com/eu/Align
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow @Veeva_EU on Twitter: twitter.com/veeva_eu
Like Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 550 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit www.veeva.com/eu .
This release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the company’s filing on Form 10-Q for the period ended 31 July, 2017. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at sec.gov . Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
TAKEDA15.12.2017 13:36 | pressemeddelelse
Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease
TWISPAY15.12.2017 13:23 | pressemeddelelse
Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards
PEACE-FORUM15.12.2017 12:40 | pressemeddelelse
Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum
CA-KENNEDY-WILSON15.12.2017 12:02 | pressemeddelelse
Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million
NV-NAC-FOUNDATION15.12.2017 10:02 | pressemeddelelse
AML BitCoin Enters Phase II of ICO
THE-CITY-OF-JOENSUU15.12.2017 09:26 | pressemeddelelse
Joensuu City Challenge – International Competition for Innovative SMEs Opened
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum